Close

Intec Pharma (NTEC) Granted U.S. Patent for Accordion Pill

May 24, 2017 8:33 AM EDT Send to a Friend
Intec Pharma Ltd. (Nasdaq: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pillâ„¢ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login